Origami Therapeutics, Inc.

Active · Oral drugs to halt neurodegeneration

YC W22

Website YC profile

Why it ranks

How the rank works

8signal of 100 · rising 2

went through YCProgram · this site+4
team of 4Team size · YC's directory+3.6

A sum of public facts, not a judgement and not investment advice.

Competitors

OtherInactiveGerostate AlphaShared: developing novel, therapeutics, biotechYC S18San FranciscoStartup →Other

Serna BioShared: small molecule, drug discovery, biotechYC W21San FranciscoStartup →Other

Eris BiotechShared: small molecule, drug discovery, therapeuticsYC W24Salt Lake CityStartup →OtherPublicPardes BiosciencesShared: oral drug, therapeutics, biotechYC S20San FranciscoStartup →AI

SFA TherapeuticsShared: oral drug, biotech, diseaseYC S21PhiladelphiaStartup →

Companies closest to Origami Therapeutics, Inc.
Company	Category	Status	Program
Gerostate AlphaShared: developing novel, therapeutics, biotechYC S18InactiveOther	Other	Inactive	YCS18
Serna BioShared: small molecule, drug discovery, biotechYC W21ActiveOther	Other	Active	YCW21
Eris BiotechShared: small molecule, drug discovery, therapeuticsYC W24ActiveOther	Other	Active	YCW24
Pardes BiosciencesShared: oral drug, therapeutics, biotechYC S20PublicOther	Other	Public	YCS20
SFA TherapeuticsShared: oral drug, biotech, diseaseYC S21ActiveAI	AI	Active	YCS21

Adjacent

Altay TherapeuticsShared: small molecule, drug discovery, therapeuticsYC W20San FranciscoStartup →AI

Exin TherapeuticsShared: drug discovery, therapeutics, biotechYC W25San FranciscoStartup →Other

SynsoryBioShared: therapeutics, biotech, drugYC W24BostonStartup →AI

Harmonic DiscoveryShared: drug discovery, biotech, diseaseYC S21New York CityStartup →Other

ParcelBioShared: drug discovery, therapeutics, biotechYC W24San FranciscoStartup →

Companies next to Origami Therapeutics, Inc.
Company	Category	Status	Program
Altay TherapeuticsShared: small molecule, drug discovery, therapeuticsYC W20ActiveAI	AI	Active	YCW20
Exin TherapeuticsShared: drug discovery, therapeutics, biotechYC W25ActiveAI	AI	Active	YCW25
SynsoryBioShared: therapeutics, biotech, drugYC W24ActiveOther	Other	Active	YCW24
Harmonic DiscoveryShared: drug discovery, biotech, diseaseYC S21ActiveAI	AI	Active	YCS21
ParcelBioShared: drug discovery, therapeutics, biotechYC W24ActiveOther	Other	Active	YCW24

Also from W22

All of W22

Brown FoodsMaking 'REAL' Cow and Human Milk!YC W22BostonStartup →DataInactive

FlowDeployBioinformatics pipelines in the cloudYC W22San FranciscoStartup →AIAcquired

HypaHubA Cloud-Based Bioinformatics and AI PlatformYC W22San FranciscoStartup →AI

InvertData analytics software for biomanufacturing.YC W22San FranciscoStartup →AI

Rosebud BiosciencesGrowing micro-organs to find new drugsYC W22San FranciscoStartup →AI

AgaveApplied AI for ConstructionYC W22San FranciscoStartup →

Company	Category	Status
Brown FoodsMaking 'REAL' Cow and Human Milk!team of 5ActiveAI	AI	Active
FlowDeployBioinformatics pipelines in the cloudteam of 3InactiveData, Devtools	Data, Devtools	Inactive
HypaHubA Cloud-Based Bioinformatics and AI Platformteam of 6acquiredAcquiredAI, Data	AI, Data	Acquired
InvertData analytics software for biomanufacturing.team of 25hiringActiveAI	AI	Active
Rosebud BiosciencesGrowing micro-organs to find new drugsteam of 3ActiveAI	AI	Active
AgaveApplied AI for Constructionteam of 50hiringActiveAI	AI	Active

About Origami Therapeutics, Inc.

Origami Therapeutics, Inc. is a biotech company developing novel protein degraders with potential to delay or halt disease progression by eliminating toxic proteins from the body. Our drug discovery platform leverages our proprietary human disease models developed to select the small molecules with the best chance of clinical success. Our first indication is Huntington’s disease, a debilitating, progressive and ultimately fatal disorder caused by a genetic mutation. We have already identified small molecules that reduce the toxic mutated protein, suppress mutant protein-induced toxicities in human disease neurons and get into the brain. We anticipate that this approach will be broadly applicable to traditionally “undruggable” targets in other neurological diseases.

YC batch: W22 · Winter 2022
Status, per YC: Active
Category: Other
Team size: 4
Location: San Diego, CA, USA
Checked: 7h ago

YC tags: Biotech, Therapeutics, Drug discovery

Origami Therapeutics, Inc. in W22: 398 companies, 45% AI

Origami Therapeutics, Inc.: questions

Which YC batch was Origami Therapeutics, Inc. in?

Origami Therapeutics, Inc. was in Y Combinator's Winter 2022 batch (W22).

Is Origami Therapeutics, Inc. still active?

Y Combinator lists Origami Therapeutics, Inc. as active.

Where is Origami Therapeutics, Inc. based?

Origami Therapeutics, Inc. lists San Diego, CA, USA as its location on YC's directory.